Veru Stock News

MIAMI, FL, April 27, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for oncology and SARS-CoV-2 and other viral ARDS-related disea

Can these top tips help your penny stocks trading? The post Advanced Penny Stocks Research Methods appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Veru (NASDAQ: VERU ) stock is getting a boost on Friday after the company revealed plans to sell its ENTADFI capsule business. That sale has the company agreeing to sell the business for $20 million t

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

MIAMI, FL., March 07, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for on

Veru (NASDAQ: VERU ) stock is taking a beating on Friday after the FDA denied the company's request for EUA for its Covid-19 treatment. That rejection has to do with sabizabulin, which is Veru's drug

Share of Veru Inc. VERU, +0.53% plunged 31.0% toward a 2 1/2-year low in premarket Friday, after the U.S. Food and Drug Administration turned down the biopharmaceutical company's request for Emergency

Veru Inc. is eyeing emergency use authorization for its COVID-19 drug Sabizabulin, which is currently under FDA review. Veru Inc. shares fell around 20% to a 52-week low after reporting Q1 FY23 result

Veru Inc. (NASDAQ:VERU ) Q1 2023 Earnings Conference Call February 9, 2023 8:00 AM ET Company Participants Sam Fisch - Executive Director, Investor Relations & Corporate Communications Mitchell Steine

Veru Inc. (VERU) delivered earnings and revenue surprises of -21.05% and 50.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

MIAMI, FL, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for onco

One of last year's surprise hits in the biotech sphere, Veru (NASDAQ: VERU ) is making headlines once again today. Currently, VERU stock is up 8%.

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Corning Incorporated (NYSE: GLW) is "fine." When asked about Axon Enterprise Inc (NASDAQ: AXON), he said, "It’s a terrific law enforcemen

Despite the recent sell-off, you'd still have a solid profit on Veru if you bought the stock nearly three years ago.

Investing in small-cap stocks is usually a very risky business, but they could offer quick and hefty returns.